News

Rapid genome editing by CRISPR-Cas9-POLD3 fusion

We are delighted to present our newest article, “Rapid genome editing by CRISPR-Cas9-POLD3 fusion”, published in eLife in December 2021.

Abstract

Precision CRISPR gene editing relies on the cellular homology-directed DNA repair (HDR) to introduce custom DNA sequences to target sites. The HDR editing efficiency varies between cell types and genomic sites, and the sources of this variation are incompletely understood.

Here, we have studied the effect of 450 DNA repair protein-Cas9 fusions on CRISPR genome editing outcomes. We find the majority of fusions to improve precision genome editing only modestly in a locus- and cell-type specific manner.

We identify Cas9-POLD3 fusion that enhances editing by speeding up the initiation of DNA repair. We conclude that while DNA repair protein fusions to Cas9 can improve HDR CRISPR editing, most need to be optimized to the cell type and genomic site, highlighting the diversity of factors contributing to locus-specific genome editing outcomes.

Rapid Genome Editing

Latest news

We have a post-doc position currently open, focusing on single-cell sequencing of the CRISPR-corrected cells.
Kata went to American Society of Gene and Cell Therapy (ASGCT) conference in Baltimore, which focuses on novel translational findings in the field.
We had the pleasure of attending the 41st NSI Annual Meeting on November 24th, 2023!
We're excited to present our newest publication, published in the STAR Protocols journal in December 2023.
His lecture was titled “Kurativ behandling av monogenetiske sykdommer med genterapi. En ny tidsalder?” (Curative treatment of monogenetic diseases with gene therapy. A new age?).